Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Ugenskienė, R"'
Autor:
Kaušylaitė MM; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Jurevičė J; Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Korobeinikova E; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Gudaitienė J; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Juozaitytė E; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Ugenskienė R; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.; Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Publikováno v:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Nov 20; Vol. 60 (11). Date of Electronic Publication: 2024 Nov 20.
Publikováno v:
Cancer Management and Research, Vol Volume 13, Pp 1123-1133 (2021)
Aistė Savukaitytė,1 Greta Gudoitytė,1 Agnė Bartnykaitė,1 Rasa Ugenskienė,1,2 Elona Juozaitytė3 1Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, Kaunas, Lithuania; 2Institute of Biology Systems and
Externí odkaz:
https://doaj.org/article/806a573431bb4d3ab6d8b5f52f20e068
Autor:
Vadeikienė R; Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Jakštys B; Research on Delivery of Medicine and Genes Cluster, Faculty of Natural Sciences, Vytautas Magnus University, LT-44001 Kaunas, Lithuania., Laukaitienė D; Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Šatkauskas S; Research on Delivery of Medicine and Genes Cluster, Faculty of Natural Sciences, Vytautas Magnus University, LT-44001 Kaunas, Lithuania., Juozaitytė E; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Ugenskienė R; Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Sep 12; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 12.
Autor:
Dambrauskienė R, Gerbutavičius R, Ugenskienė R, Jankauskaitė R, Savukaitytė A, Šimoliūnienė R, Rudžianskienė M, Gerbutavičienė R, Juozaitytė E
Publikováno v:
Balkan Journal of Medical Genetics, Vol 20, Iss 1, Pp 35-42 (2017)
The most important complications of Philadelphianegagive (non BCR-ABL) myeloproliferative neoplasms (MPNs) are vascular events. Our aim was to evaluate the effects of single nucleotide polymorphisms (SNPs), platelet glycoproteins (GPs) (Ia/IIa, Ibα,
Externí odkaz:
https://doaj.org/article/74fbf3995b1d4649a2e774892735ad72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Balčiūnienė E; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Inčiūra A; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Juozaitytė E; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania., Ugenskienė R; Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Mar 22; Vol. 16 (7). Date of Electronic Publication: 2024 Mar 22.
Autor:
Stakišaitis D; Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.; Laboratory of Molecular Oncology, National Cancer Institute, 08660 Vilnius, Lithuania., Kapočius L; Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania., Tatarūnas V; Institute of Cardiology, Laboratory of Molecular Cardiology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania., Gečys D; Institute of Cardiology, Laboratory of Molecular Cardiology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania., Mickienė A; Department of Infectious Diseases, Lithuanian University of Health Sciences, 47116 Kaunas, Lithuania., Tamošuitis T; Department of Intensive Care Medicine, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania., Ugenskienė R; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania., Vaitkevičius A; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius University, 08661 Vilnius, Lithuania., Balnytė I; Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania., Lesauskaitė V; Institute of Cardiology, Laboratory of Molecular Cardiology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Mar 16; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 16.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.